1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > 2015 New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape

2015 New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape

  • June 2015
  • -
  • Venture Planning Group
  • -
  • 973 pages

Summary

Table of Contents

2015 New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.


Rationale


The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.


Market Segmentation


- Review of POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.


- Five-year test volume and reagent sales forecasts for chemistry, 

  immunodiagnostic, microbiology, hematology and coagulation procedures by market

  segment:



- Emergency Rooms       

- Operating/Recovery Suites      

- ICUs/CCUs 

  

   and by test category:


- Routine and Special Chemistry   

- Microbiology/Infectious Diseases   

- Hematology          

- Flow Cytometry         

- Coagulation     

- Immunoproteins

- Drugs of Abuse

- TDM

- Endocrine Function

- Tumor Markers


Sales and Market Share Analysis


- Sales and market shares of major reagent and instrument suppliers.


Current and Emerging Tests and Instrumentation


- Analysis of over 130 diagnostic procedures.


- Review of leading chemistry, immunoassay, hematology and coagulation analyzers market by

Abaxis, Abbott, Alfa Wasserman, Awareness Technologies, Beckman Coulter/Danaher, Becton Dickinson, Behnk Elektronik, Biocode, Bio/Data, bioMerieux, Cardiovascular Diagnostics, Carolina Chemistries, Diagnostica Stago, Diesse Ves Matic, Drew-Scientific, Helena Laboratories, Horiba, Instrumentation Laboratory, Inverness, ITC Hemochron, Medica, Menarini, Nihon Kohden, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Sysmex, Teco Medical Instruments, Trinity Biotech, and other suppliers.


Technology Review


- Emerging technologies and their applications for POC testing.


- Comprehensive listings of companies developing or marketing POC diagnostic technologies

  and products, by test.


Strategic Recommendations


- Specific opportunities for new POC instruments and reagent systems with potentially

  significant market appeal during the next five years.


- Design criteria for POC testing products.


- Alternative business expansion strategies.


- Potential market entry barriers and risks.


Competitive Assessments


- Assessments of major suppliers and emerging market entrants, including their sales, product

  portfolios, marketing tactics, joint ventures, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - ADI/American Diagnostica

   - Agilent Technologies

   - Axis-Shield

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Bio/Data

   - Biomerieux

   - Bio-Rad

   - Biosite/Inverness/Alere

   - Cepheid      

   - Chrono-Log

   - Corgenix

   - Decode

   - Diadexus

   - Diagnocure

   - Diagnostica Stago/Trinity Biotech

   - Diamedix           

   - Diasorin

   - Eiken Chemical

   - EKF Diagnostics

   - Fujirebio

   - Grifols

   - Helena Laboratories

   - Hologic/Gen-Probe

   - Horiba

   - Instrumentation Laboratory

   - International Technidyne/Nexus DX

   - Kreatech/Leica

   - Kyowa Medex

   - Lonza

   - Mackay Life Sciences

   - Matritech

   - Nihon Kohden

   - Ortho-Clinical Diagnostics

   - Polartechnics

   - Polymedco

   - Qiagen

   - Roche

   - SDIX

   - Sequenom

   - Siemens

   - Sienco

   - Sysmex

   - Takara Bio

   - ThermoFisher/Life Technologies

   - Tosoh

   - Wako

   - Zycare/Alere


Methodology


This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.


Contains 973 pages and 153 tables

“2015 New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • March 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 21100
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2017 Competing in the Global Cancer Diagnostics Market

2017 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


Download Unlimited Documents from Trusted Public Sources

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Hospital Industry

  • April 2017
    166 pages
  • Health Care Pro...  

    Hospital  

View report >

Hospital Industry in the US

  • April 2017
    5 pages
  • Hospital  

    Digestive Syste...  

  • United States  

View report >

Healthcare Industry

8 days ago

Hospital Industry

13 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.